FETNEURIA Trademark

Trademark Overview


On Monday, August 7, 2023, a trademark application was filed for FETNEURIA with the United States Patent and Trademark Office. The USPTO has given the FETNEURIA trademark a serial number of 79378370. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by Telix Pharmaceuticals Limited. The FETNEURIA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer

Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use
fetneuria

General Information


Serial Number79378370
Word MarkFETNEURIA
Filing DateMonday, August 7, 2023
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7435769
Registration DateTuesday, July 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesChemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer
Goods and ServicesMedical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 13, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTelix Pharmaceuticals Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameTelix Pharmaceuticals Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU

Party NameTelix Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Thursday, September 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 12, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, September 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 19, 2023APPLICATION FILING RECEIPT MAILED
Thursday, March 14, 2024ASSIGNED TO EXAMINER
Monday, March 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTICE OF PUBLICATION
Thursday, August 8, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB